ARCT Arcturus Therapeutics
- 17.940
- +0.870+5.10%
- 18.260
- +0.320+1.78%
Arcturus Therapeutics News
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kurata Lance
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Payne Joseph E
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer SASSINE ANDY
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Arcturus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nikko Asset Management Americas, Inc.(8.56%)
Arcturus Therapeutics | 10-Q: Q3 2024 Earnings Report
Arcturus Therapeutics | 8-K: Current report
Arcturus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sumitomo Mitsui Trust Group, Inc. (“SMTG”)(8.56%),Nikko Asset Management Co., Ltd. (“NAM”)(8.56%)
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chivukula Pad
Arcturus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Arcturus Therapeutics | 8-K: Current report
Arcturus Therapeutics | 10-Q: Q2 2024 Earnings Report
Arcturus Therapeutics | 8-K: Current report
Arcturus Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Arcturus Therapeutics | 8-K: Current report
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Slaoui Moncef
Arcturus Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Slaoui Moncef
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marantz Jing L.
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HOLMES EDWARD W
Arcturus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Markels John
No Data